These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 13957)

  • 1. The relationship of pharmacokinetics to pharmacological activity: morphine, methadone and naloxone.
    Berkowitz BA
    Clin Pharmacokinet; 1976; 1(3):219-30. PubMed ID: 13957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of naloxone in rats and in man: basis for its potency and short duration of action.
    Ngai SH; Berkowitz BA; Yang JC; Hempstead J; Spector S
    Anesthesiology; 1976 May; 44(5):398-401. PubMed ID: 1267205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Disposition of naloxone: use of a new radioimmunoassay.
    Berkowitz BA; Ngai SH; Hempstead J; Spector S
    J Pharmacol Exp Ther; 1975 Dec; 195(3):499-504. PubMed ID: 1195133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-dose morphine and methadone in cancer patients. Clinical pharmacokinetic considerations of oral treatment.
    Säwe J
    Clin Pharmacokinet; 1986; 11(2):87-106. PubMed ID: 3514045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between narcotic analgesics and benzodiazepine derivatives on behavior in the mouse.
    Shannon HE; Holtzman SG; Davis DC
    J Pharmacol Exp Ther; 1976 Nov; 199(2):389-99. PubMed ID: 10428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tolerance, dependence and lethality in morphine-dependent mice after repeated oral administration of methadone.
    Masten LW; Hine CH; Way EL
    Drug Alcohol Depend; 1978 Nov; 3(6):405-18. PubMed ID: 569043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of a sustained naloxone delivery system in rats.
    Fishman J; Hahn EF; Norton BI; Ronai A; Foldes FF
    Pharmacology; 1975; 13(6):513-9. PubMed ID: 1221433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reinitiation of sensitivity to naloxone by a single narcotic injection in postaddicted mice.
    Brase DA; Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 May; 197(2):317-25. PubMed ID: 944771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.
    Iorio LC; Deacon MA; Ryan EA
    J Pharmacol Exp Ther; 1975 Jan; 192(1):58-63. PubMed ID: 1168251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methadone in man: pharmacokinetic and excretion studies in acute and chronic treatment.
    Verebely K; Volavka J; Mulé S; Resnick R
    Clin Pharmacol Ther; 1975 Aug; 18(2):180-90. PubMed ID: 1149368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of morphine and its surrogates. VIII: Naloxone and naloxone conjugate pharmacokinetics in dogs as a function of dose and as affected by simultaneously administered morphine.
    Garrett ER; Shyu WC; Ulubelen A
    J Pharm Sci; 1986 Dec; 75(12):1127-36. PubMed ID: 3559921
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of morphine and its surrogates. VII: High-performance liquid chromatographic analyses and pharmacokinetics of methadone and its derived metabolites in dogs.
    Garrett ER; Derendorf H; Mattha AG
    J Pharm Sci; 1985 Nov; 74(11):1203-14. PubMed ID: 4087182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidural and intrathecal opiates: cerebrospinal fluid and plasma profiles in patients with chronic cancer pain.
    Max MB; Inturrisi CE; Kaiko RF; Grabinski PY; Li CH; Foley KM
    Clin Pharmacol Ther; 1985 Dec; 38(6):631-41. PubMed ID: 2415286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in the efficacy of naloxone induced by stress, cyclic adenosine monophosphate, and morphine tolerance.
    Harris RA; Loh HH; Way EL
    Eur J Pharmacol; 1976 Sep; 39(1):1-10. PubMed ID: 183962
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circling behavior after narcotic drugs and during naloxone-precipitated abstinence in rats with unilateral nigral lesions.
    Iwamoto ET; Loh HH; Way EL
    J Pharmacol Exp Ther; 1976 Jun; 197(3):503-16. PubMed ID: 945346
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naloxone rapidly evokes endogenous kappa opioid receptor-mediated hyperalgesia in naïve mice pretreated briefly with GM1 ganglioside or in chronic morphine-dependent mice.
    Crain SM; Shen KF
    Brain Res; 2007 Sep; 1167():31-41. PubMed ID: 17692296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma arginine vasopressin response to intravenous methadone and naloxone in conscious dogs.
    Hellebrekers LJ; van den Brom WE; Mol JA
    J Pharmacol Exp Ther; 1989 Jan; 248(1):329-33. PubMed ID: 2913278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparative study of the efficacy and pharmacokinetics of oral methadone and morphine in the treatment of severe pain in patients with cancer.
    Gourlay GK; Cherry DA; Cousins MJ
    Pain; 1986 Jun; 25(3):297-312. PubMed ID: 3528988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single dose pharmacokinetics and bioavailability of methadone in man studied with a stable isotope method.
    Meresaar U; Nilsson MI; Holmstrand J; Anggård E
    Eur J Clin Pharmacol; 1981; 20(6):473-8. PubMed ID: 7286059
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.
    Johnsson G; Regàrdh CG
    Clin Pharmacokinet; 1976; 1(4):233-63. PubMed ID: 13958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.